non-small-cell lung carcinoma
Give an agent a durable, checkable way to recognise a non-small-cell lung carcinoma, record what state it is in, and decide what may be done with it.
Generated draft, first pass
This model was drafted by rule from what the registry knows about the thing. It proposes which bundles a real model will need and which questions research must answer. It is not researched and no sentence in it is sourced.
Generator: vr.draft.v3
Bundle → Layer → Finding → Questions Derived, awaiting review
5 bundles · 10 layers · 12 findings · 32 questions
Identity, naming and classification How an agent tells one non-small-cell lung carcinoma from another, and a non-small-cell lung carcinoma from things that resemble it.
Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.
Names and identifiers
The names this thing goes by and the identifiers that survive translation and time.
Preferred name, aliases and local names
Which name to use, which names mean the same thing, and which merely sound similar.
- What identifies and describes the name of a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about the name of a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once the name of a non-small-cell lung carcinoma is known, and what must it refuse? action
Stable identifiers and external keys
Identifiers that keep pointing at this kind of thing across systems and languages.
- What identifies and describes an identifier for a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about an identifier for a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once an identifier for a non-small-cell lung carcinoma is known, and what must it refuse? action
Classification and granularity
Where a non-small-cell lung carcinoma sits among kinds, and how finely a task needs to cut it.
Kind, parents and neighbouring kinds
The classes this thing belongs to and the ones it is next to.
- What identifies and describes the kind of a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about the kind of a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once the kind of a non-small-cell lung carcinoma is known, and what must it refuse? action
Distinguishing features
What separates a non-small-cell lung carcinoma from the things most often confused with it.
- What identifies and describes what distinguishes a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about what distinguishes a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once what distinguishes a non-small-cell lung carcinoma is known, and what must it refuse? action
State and lifecycle The states a non-small-cell lung carcinoma passes through and the events that move it between them.
Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.
Lifecycle stages
From coming into existence to ceasing to be one of these.
Stages and transitions
The stages worth naming and what moves a non-small-cell lung carcinoma between them.
- What identifies and describes the lifecycle of a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about the lifecycle of a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once the lifecycle of a non-small-cell lung carcinoma is known, and what must it refuse? action
Observations and current status
What is observed about a non-small-cell lung carcinoma, how often and by whom.
Observation record
How an observation of a non-small-cell lung carcinoma is recorded so that it can be superseded rather than overwritten.
- What identifies and describes an observation of a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about an observation of a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once an observation of a non-small-cell lung carcinoma is known, and what must it refuse? action
Definitions and who holds them What non-small-cell lung carcinoma is taken to mean, and by whom.
When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.
Competing definitions
The main readings and the traditions behind them.
Definitions and their holders
Each definition with the school or body that holds it.
- Which definitions of non-small-cell lung carcinoma are in use, and which tradition or body holds each? definition
- What turns on the difference between them in practice? boundary
Operationalisation
How it is measured or applied when it has to be.
Measures and proxies
Instruments and indicators used to stand in for it.
- How is non-small-cell lung carcinoma operationalised or measured in practice, and by what instrument? measurement
- What does that operationalisation leave out, and when does that matter? boundary
Instances, use and consequence What counts as an instance of non-small-cell lung carcinoma and what follows from calling something that.
Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.
What counts as an instance
Clear cases, borderline cases and non-cases.
Tests for an instance
What would settle whether something falls under it.
- What would settle whether something is an instance of non-small-cell lung carcinoma? boundary
- Which borderline cases are argued about, and on what grounds? definition
Consequence of application
Rights, duties or decisions that follow from the label.
What the label licenses
What an agent may do once something is classified this way.
- What follows practically once something is treated as non-small-cell lung carcinoma? action
- What must an agent not infer from the label alone? action
Provenance, evidence and time Where every claim about a non-small-cell lung carcinoma came from and when it held.
A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.
Source and authority
Who said it, on what evidence, and how strongly.
Claim provenance and confidence
The authority behind each claim about a non-small-cell lung carcinoma and how confident it is.
- What identifies and describes a claim about a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about a claim about a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once a claim about a non-small-cell lung carcinoma is known, and what must it refuse? action
Time, versions and supersession
When a claim was true, when it was learnt, and what replaced it.
Validity period and supersession
How an old claim about a non-small-cell lung carcinoma is retired without being erased.
- What identifies and describes the validity of a claim about a non-small-cell lung carcinoma, and in what units or vocabulary? definition
- Who or what asserted this about the validity of a claim about a non-small-cell lung carcinoma, by which method, and when was it true? provenance
- What may an agent decide or do once the validity of a claim about a non-small-cell lung carcinoma is known, and what must it refuse? action
Classifiers Filled
- Family
- Thing Registry
- Category
- Cross-cutting context
- Entry kind
- abstract concept
- Plane
- XCT
- Domain
- XCT.STA
- Other names and narrower kinds
- ovarian large-cell neuroendocrine carcinoma, large cell neuroendocrine carcinoma, large-cell lung carcinoma, basaloid large cell carcinoma of the lung, Sarcomatoid carcinoma of the lung, lung occult non-small cell carcinoma, non small cell lung cancer recurrent, lung non-squamous non-small cell carcinoma, lung occult large cell carcinoma, large cell carcinoma with rhabdoid phenotype, lymphoepithelioma-like lung carcinoma, large cell lung carcinoma, clear cell variant
What it is Derived, awaiting review
A cross-cutting notion registered under XCT.STA. The registry names it; this draft has not been given a definition yet.
Why it exists Derived, awaiting review
Give an agent a durable, checkable way to recognise a non-small-cell lung carcinoma, record what state it is in, and decide what may be done with it.
Distinguishing features Derived, awaiting review
- Names folded into this entry, which a task may need to split apart again: ovarian large-cell neuroendocrine carcinoma, large cell neuroendocrine carcinoma, large-cell lung carcinoma, basaloid large cell carcinoma of the lung, Sarcomatoid carcinoma of the lung, lung occult non-small cell carcinoma, non small cell lung cancer recurrent, lung non-squamous non-small cell carcinoma, lung occult large cell carcinoma, large cell carcinoma with rhabdoid phenotype, lymphoepithelioma-like lung carcinoma, large cell lung carcinoma, clear cell variant.
- 14 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.
- Described in 16 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is.
What robots and AI may and may not do Derived, awaiting review
May
- observe it, measure it, record its state
Moral aspects Missing, in the backlog
Not described yet. This gap is in the card backlog.
Owners Missing, in the backlog
Not described yet. This gap is in the card backlog.
Links to other meta-models Derived, awaiting review
related
- ovarian large-cell neuroendocrine carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- large cell neuroendocrine carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- large-cell lung carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- basaloid large cell carcinoma of the lung - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- Sarcomatoid carcinoma of the lung - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- lung occult non-small cell carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- non small cell lung cancer recurrent - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- lung non-squamous non-small cell carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- lung occult large cell carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- large cell carcinoma with rhabdoid phenotype - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- lymphoepithelioma-like lung carcinoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
- large cell lung carcinoma, clear cell variant - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
What else AI and robots need to interact with it Incomplete
Identity and identifiers required Missing, in the backlog
Not described yet. This gap is in the card backlog.
Direct properties not applicable Not applicable
- Made of: an abstraction with no physical instance
- Does nothing on its own; everything it does, something else did to it.
- These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing.
Recognition optional Derived, awaiting review
- Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about.
Capabilities and actions required Derived, awaiting review
- observed and measured
Hazards and failure modes required Missing, in the backlog
Not described yet. This gap is in the card backlog.
Standards and interfaces required Missing, in the backlog
Not described yet. This gap is in the card backlog.
Context of use required Derived, awaiting review
- Described in 16 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 14 finer distinctions are held inside this entry as names rather than as separate models.
Sources Missing, in the backlog
Not described yet. This gap is in the card backlog.
Open questions
- Which of the bundles below does a real task actually need, and which are ceremony?
- What does this thing have that the facets do not capture at all?
- Which neighbouring kind is most often confused with a non-small-cell lung carcinoma, and on what evidence are they told apart?
- What may an agent decide or do once the name of a non-small-cell lung carcinoma is known, and what must it refuse?
- What may an agent decide or do once an identifier for a non-small-cell lung carcinoma is known, and what must it refuse?
- What may an agent decide or do once the kind of a non-small-cell lung carcinoma is known, and what must it refuse?
Machine files
Provenance
thing registry, generated draft (pass 1) · not researched
Built from: models/draft_model.php, wikidata
Generated by rule from registry facets. No source was read; every derived section awaits the research pass.